3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Obese women face greater multiple myeloma risk

CancerSep 27, 05

The results of a new prospective study provide additional evidence that obesity may increase women’s risk of developing multiple myeloma, a type of bone-marrow cancer.

Results of studies looking into a potential link between excess weight and multiple myeloma have been inconsistent, Cindy K. Blair of the University of Minnesota Cancer Center in Minneapolis and her colleagues note in the medical journal Epidemiology.

Past studies have used different measurements to gauge obesity, Blair noted in an interview with Reuters Health. To clarify the relation between multiple myeloma and obesity, she and her colleagues used several characteristics to investigate the association, including body mass index (BMI)—a measure of weight in relation to height—as well as weight alone, waist-to-hip ratio, and individual waist and hip measurements.

In a group of 37,083 post-menopausal women followed for 16 years, Blair and her team found that several of these characteristics conferred greater risk.

Those with a BMI of 30 or greater (i.e., in the obese range) were 1.5 times more likely to develop multiple myeloma, while those with the greatest weight, waist circumference or hip circumference had roughly doubled the risk. However, there was no relationship between waist-to-hip ratio and multiple myeloma risk.

While much work has been done on the association between obesity and other cancers, Blair notes, the idea that excess weight may be linked to bone-marrow cancers is newer.

SOURCE: Epidemiology, September 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site